Almac's clinical Supply Chain Management service combines consultancy and supportive technology that helps sponsor companies
Almac’s best-in-class clinical Supply Chain Management (SCM) service combines consultancy and supportive technology that helps sponsor companies overcome technological, logistical and planning challenges increasingly experienced by biotech and pharma companies conducting global clinical trials.
As clinical studies become truly global, sponsor companies face challenges with shorter availability of complex investigational products, variable patient demands and the pressures on an increasingly stretched global supply chain. Coupled with the need for global provision of expensive comparators, sponsors are seeking oversight across all aspects of their clinical supply chain.
Almac have continued developing their unique SCM service that blends consultancy, supportive technology and end-to-end supply chain visibility. This gives sponsors more control over the complete supply chain, driving down costs, reducing timeframes and aligning clinical supply with patient demand globally.
The Almac solution of single system integration of forecasting, Material Resource Planning (MRP) and Interactive Response Technology (IRT) provides data in real-time. As a consequence, the dedicated SCM experts are able to assume responsibility to make key decisions, thereby ensuring reliable and efficient supply of clinical trial material to meet patient demand.
Almac’s latest service offering further enhances and supplements their core manufacturing, packaging and distribution services for investigational products and offers clients the best and most comprehensive clinical supply chain management solution available on the global marketplace.
Michelle Foust, Almac’s Director of Supply Chain Strategy stated “Almac has been providing clinical SCM for over 25 years and in response to the challenges experienced by our global client base, we have developed novel solutions for use across multiple study types. Indeed, we are confident that our consultancy-based offering optimizes clinical trial supply, thereby minimising waste and decreasing costs for our partners.”
Find out more about clinical Supply Chain Management – http://www.almac-scm.com
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.